Obesity and Diabetes Flashcards

1
Q

Obesity

A

Major worldwide health problem
Defined BMI > 30 kg/m² - also consider muscle mass
Discuss diet/exercise at each visit
Ask health goals, what are they doing to meet their goals, do they need help meeting their goals
Consider referral to a dietitian
Consider weight loss medications
Consider referral to a bariatric specialty center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

BMI

A
Underweight- <18.5
Normal 18.5-24.9
Overweight- 25.0-29.0
Obese- 30.0-40.0
Extreme Obese- >40
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Diets

A

Restricted carbohydrate diets (Atkins, Keto)
May be difficult to sustain long-term, tends to have a higher overall weight loss (especially initially)
Low fat diets
Tends to be higher fiber, good for heart disease
Low calorie diets (weight watchers, fasting)
More effective than low fat
Multiple other diets – Mediterranean & DASH highly rated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exercise

A

Exercise should always be recommended if patient is healthy enough for participation
Exercise alone results in lower weight loss than when combined with diet
60-90 minutes of moderate intensity exercise daily
Usually cardiovascular exercise is most effective
Strength training can aid in long-term goals and improvement in body shape (losing inches)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Weight Loss Medications

A

Check current medication list for those than may cause weight gain and/or interactions
Generally for those with BMI > 30 or > 27 with medical conditions
Orlistat (Alli) – blocks absorption (OTC)
May cause flatulence, fatty stool, increased stool, incontinence
Lorcaserin (Belviq) – activates specific receptors (controlled)
Caution in heart disease, may lose 5% of body weight
Liraglutide (Saxenda) – GLP-1 (injectable)
High GI side effects, may lose 5-10% body weight
Phentermine/topiramate (Qsymia)
High number of CNS side effects, may lose 5-7%
Bupropion/naltrexone (Contrave) – decrease appetite
May have strange dreams, insomnia, may lose 5%
Phentermine (controlled)
Can only be used in the short term
Other drugs used off-label
Methylphenidate, zonisamide, octreotide, metformin, Victoza, bupropion, Topamax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bariatric Surgery

A

Lap Band (Restrictive)
Average loss 40-50% excess body weight, high complication rate
Gastric Sleeve (Restrictive)
Average loss of >50% excess body weight
Gastric Bypass (Restrictive/Malabsorptive)
Average loss of 60-80% excess body weight
Duodenal Switch (Malabsorptive)
Average loss of >70% excess body weight long-term
Risks of surgery
Dumping syndrome, dehydration, N/V, constipation, obstruction, gaining weight back or failure to lose weight, plus normal risks of all surgeries (PE/DVT, pneumonia, death, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Long-term Monitoring after Bariatric Surgery

A

After bariatric surgery (generally lifelong):
Daily vitamins – MVI, Vitamin D, Calcium, Vitamin B12
Healthy lifestyle choices – diet/exercise, high protein diet
Fluid intake 64 ounces or more daily
No NSAIDs, may require PPIs long-term
No smoking, restricted alcohol (absorption changes)
No eating/drinking together, avoid soups
No carbonated beverages, avoid straws
Should have yearly:
CBC, CMP, Thyroid panel, Lipid panel, Iron panel, Vitamin B12, Folic Acid, Hemoglobin A1c, Ferritin, Magnesium, Phosphorus, Vitamin D, Thiamine, Vitamin B-1, RBC-Folate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 2 Diabetes Mellitus

A

Diabetes type 2 is characterized by sufficient circulating endogenous insulin, resistance to insulin action and an inadequacy of compensatory insulin secretion response (Dunphy, 2013).
Insulin resistance in target tissues, abnormal insulin secretion and decreases in insulin receptors causes unique propensities for microvascular and macrovascular complications (Hollier & Hensley 2011).
Significant morbidity and mortality are realized as a result of type 2 diabetes. Complications from this disease are seen most notably in the eyes, kidneys, nerves and heart (Khavandi et al., 2013).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T2DM Pathophysiology

A

Type 2 DM is associated with 2 abnormalities: insulin resistance and impaired insulin secretion.
As insulin resistance increases, insulin levels begin to rise but the glucose level remains normal. This causes a state of hyperinsulinemia.
The compensatory hyperinsulinemia fails to keep pace when the blood glucose begins to rise.
There is a decline in the endocrine function of pancreatic beta cells. This impairs insulin secretion in response to glycemic load- which produces elevated plasma glucose levels .

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T2DM Screening

A

Testing should begin at age 45
Repeat screening at 3-year intervals for normal results
Early screening should be done for people with BMI 25 or higher and with 1 or more risk factors for diabetes
Lab tests measuring glucose levels-most common test to measure diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T1DM Signs and Symptoms

A

Poluria- increased urination
Polydipsia- increased thirst
Polyphagia- increased hunger

Weight loss despite increased appetite
Fruity breath odor 
Fatigue, lethargy, drowsiness
Confusion, stupor, unconsciousness
Nocturnal enuresis
Dehydration
Increased frequency of infections
Rapid onset
Insulin-dependent
Familial tendency
Peak incidence from 10-15 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T2DM

A

3 P’s Polydipsia, polyphagia, polyuria
Sudden onset T1dm

Fatigue/Lethargy/Drowsiness 
Confusion or  stupor or unconsciousness
Obesity
Blurred vision
Peripheral neuropathy
Ketones in the urine
Infection (candida, UTI, skin, balanitis)
Hyperglycemia on Chemistry, glycosuria
Skin tags, Acanthosis nigricans
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risk Factors for T1DM

A
Family history of T1DM  / Genetics
Caucasian, Non-Hispanic
Viral exposure (Enterovirus, EBV, CMV, Coxsackievirus, and Mumps)
Exposure to cow’s milk during infancy/childhood
Vitamin D Deficiency
High socioeconomic status
Obesity
Other autoimmune disease (Grave’s disease, Addison’s disease, Hashimoto’s thyroiditis, Multiple Sclerosis, and pernicious anemia).
Perinatal factors:
	-Maternal age < 25 at time of birth
	-History of preeclampsia
	-Neonatal jaundice
	-Respiratory infection at birth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk Factors for T2DM

A

Family history

Ethnicity: AA, Hispanic, Native American, Asian American, Pacific Islander

Age greater than 45 years

Impaired fasting glucose

Hypertension, physical inactivity

Obesity, PCOS

Hyperlipidemia: HDL < 40 in men and <50 in women

Delivery of a baby > 9 lbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A1C

  • Normal
  • Prediabetes
  • Normal
A

Normal- about 5
Pre- 5.7-6.4
Diabetes- 6.5 or above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fasting Plasma Glucose

  • Normal
  • Prediabetes
  • Normal
A

Normal- 99 or below
Prediabetes 100-125
Diabetes- 126 or above

17
Q

Oral Glucose Tolerance Test

  • Diabetes
  • Prediabetes
  • Normal
A

Normal-139 or below
Prediabetes- 140-199
Diabetes- 200 or above

18
Q

DM Diagnostic Criteria

A

Fasting plasma glucose > 126 mg/dL on more than one occasion
Random venous plasma glucose > 200mg/dL
Plasma glucose >200 mg/dL taken 2 hours AFTER a glucose load of 1.75 g/kg in an oral glucose tolerance test (OGTT).
-This is seldom necessary in diagnosing T1DM
Hemoglobin A1C > 6.5
-This is more useful in diagnosing T2DM
All criteria should be confirmed via repeat testing.
C-Peptide and Insulin level
HLA (Human leukocyte antigen) typing

19
Q

Rapid-Acting Insulin

  • Brand Names
  • Onset
  • Peak
  • Duration
A

Brand Names- Humalog, Novolog, Apidra
Onset-10-30 minutes
Peak- 30 minutes to 3 hours
Duration- 3 to 5 hours

20
Q

Short-Acting

  • Brand Names
  • Onset
  • Peak
  • Duration
A

Brand names- Regular
Onset- 10-30 minutes
Peak- 2-5 hours
Duration- Up to 12 hours

21
Q

Intermediate-acting Insulin

  • Brand Names
  • Onset
  • Peak
  • Duration
A

Brand Names- NPG (N)
Onset- 1.5 to 4 hours
Peak- 4-12 hours
Duration- Up to 24 hours

22
Q

Long-acting Insulin

  • Brand Names
  • Onset
  • Peak
  • Duration
A

Brand names- Latus, Levemir
Onset- 0.8 to 4 hours
Peak-minimal peak
Duration- up to 24 hours

23
Q

Drugs that Impair Glucose Tolerance or Cause Overt DM

A
Glucocorticoids
Oral contraceptives 
Tacrolimus and cyclosporine
Nicotinic acid (niacin)
HIV protease inhibitors
Thiazide diuretics
Atypical antipsychotics
Gonadotropin releasing hormone agonists
Beta blockers
Clonidine
CCB
Pentamidine
Alcohol
24
Q

T1 vs T2

A

Due to long term complications, it becomes increasingly important to differentiate between T1DM and T2DM.
T1DM is suggested by the presence of circulating, islet-specific, pancreatic autoantibodies against glutamic acid decarboxylase (GAD65)
Low to normal levels of high fasting insulin and C-peptide are suggestive of T1DM

25
Q

DM Labs

A

HbA1C every 3 months for one year following diagnosis and initiation of insulin therapy
HbA1C can be drawn every 6 months afterward in individuals who meet treatment goals
Lipid Profile, urinalysis and serum creatinine (initially and annually)
Annual TSH, CBC, CMP
Microalbuminuria screening annually
Consider ACE, even in the absence of HTN

26
Q

DM Management

A

The initial goal of treatment in T1DM is to normalize the blood glucose level. In order to do so, all type 1 diabetics will require some form of insulin supplementation.
Types of Insulin:
-Long acting (Lantus and Levemir)
-Intermediate acting NPH (Humulin N and Novolin N)
-Short acting (Regular insulin, Novolin R, and Humulin R)
-Rapid acting (Humalog, Novolog, and Apidra)
FLEXIBLE INTENSIVE INSULIN THERAPY IS THE GOLD STANDARD.

27
Q

Goals of Glucose Management

A

GOALS OF GLUCOSE MANAGEMENT
Before meals 80 – 120 mg/dL
Bedtime 100 -140 mg/dL
Children < 12 years old are allotted a slightly higher Blood Glucose

GOALS FOR HbA1C
<6 years old		<8.5%
6 to 12 years old	<8%
13 to 19 years old	<7.5%
Over 19 years old	<7%
28
Q

T1 DM Management

A

SMBG for T1DM is optimal at 3-4 times per day (before each meal and at bedtime).
First Line Therapy
-Frequent daily injections (FDI) or continuous SC insulin infusion (CSII)
-FDI: Long acting insulin 1-2 times per day, short acting insulin based on carbohydrate count, and rapid acting insulin based on pre-meal BG
-CSII: Long acting insulin infuses continuously with regular or rapid acting insulin analogues for bolus doses
Second Line Therapy
-Conventional insulin therapy
-NPH mixed with regular or rapid insulin injected 1-2 times per day

29
Q

DM exercise

A

Regular, consistent exercise is important in maintaining and/or lowering HbA1C
T1DM must be cognizant of BG levels before, during and after exercise
-Sugars may drop, leading to hypoglycemia
-Depending on the individual, a snack may need to be consumed before, during or after the exercise
If hyperglycemic and test positive for urine ketones PRIOR to exercise, avoid vigorous/strenuous workout regimes.
-These activities may resume in the absence of urine ketones

30
Q

DM Complications

A

Hypoglycemia
DKA
Hyperlipidemia and HTN
Excessive weight gain
Chronic foot ulcers/amputations
Microvascular disease (retinopathy, nephropathy, neuropathy)
Macrovascular disease (coronary and cerebral artery disease)
Psychological problems of chronic disease

31
Q

DM Consultation/Referrals

A
At the time of diagnosis, all clients should be referred to a diabetes educator and registered dietician.
Other services to consider for referral include:
	-Endocrinology
	-Ophthalmology
	-Podiatry
	-Nephrology
	-Cardiology
	-Psychology
	-OBGYN
	-Dentist
32
Q

Health Maintenance

A
Pneumococcal vaccine
Influenza vaccine
Aspirin prophylaxis in clients > age 40
Ongoing education:
-Diet / exercise
-Smoking cessation
-Pre-conception or contraceptive counseling
-Management of risk factors
-Coping / psychological development
-Signs/symptoms of complications (DKA, hypoglycemia, etc.)
If start B-Blockers
33
Q

Newer DM Treatments

A
Byetta
Bydureon
Victoza
Symlin
Januvia
Onglyza
Tradjenta
Kombiglyze
Farxiga
34
Q

Artificial Pancreas

A

Type 1 DM
Senses blood glucose levels
Has a continuous glucose monitor with an insulin pump

35
Q

Islet Cell Transplant

A
Available in Canada, UK, and Australia
Still experimental in the United States
Transplant Islet cells into the abdomen
Cells last 3-5 years
Need to take immune suppressing drugs for life so their body won’t reject them.